We are live on ! Find out more
KFP

Keystone Financial Planning Portfolio holdings

AUM $388M
1-Year Est. Return 16.66%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+16.66%
3 Year Est. Return
+34.06%
5 Year Est. Return
+32.93%
10 Year Est. Return
+97.12%
AUM
$286M
AUM Growth
-$12.5M
Cap. Flow
+$1.6M
Cap. Flow %
0.56%
Top 10 Hldgs %
65.48%
Holding
49
New
2
Increased
12
Reduced
18
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.07M
2
K
Kellanova
K
+$564K
3
PFE icon
Pfizer
PFE
+$482K
4
VZ icon
Verizon
VZ
+$428K
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$276K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.85M
2
IBM icon
IBM
IBM
+$312K
3
PNW icon
Pinnacle West Capital
PNW
+$178K
4
CVX icon
Chevron
CVX
+$162K
5
T icon
AT&T
T
+$70.4K

Sector Composition

Rank Sector Weight
1 Consumer Staples 8.79%
2 Technology 8.15%
3 Healthcare 7.72%
4 Utilities 7.07%
5 Industrials 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYM icon
26
Vanguard High Dividend Yield ETF
VYM
$80.9B
$2.6M 0.91%
25,158
-166
-0.7% -$17.8K
MCD icon
27
McDonald's
MCD
$191B
$2.45M 0.86%
9,299
-41
-0.4% -$11.7K
KO icon
28
Coca-Cola
KO
$381B
$2.11M 0.74%
37,644
-116
-0.3% -$6.96K
UL icon
29
Unilever
UL
$141B
$2.04M 0.71%
36,754
+9
+0% +$520
USB icon
30
US Bancorp
USB
$98B
$1.99M 0.7%
60,176
-304
-0.5% -$11.1K
HLN icon
31
Haleon
HLN
$44.5B
$1.97M 0.69%
236,066
-3,643
-2% -$30.3K
GSK icon
32
GSK
GSK
$104B
$1.78M 0.62%
49,157
-614
-1% -$21.8K
JNJ icon
33
Johnson & Johnson
JNJ
$617B
$1.66M 0.58%
10,654
-176
-2% -$29K
PG icon
34
Procter & Gamble
PG
$335B
$1.29M 0.45%
8,860
– –
SNY icon
35
Sanofi
SNY
$103B
$1.24M 0.43%
23,156
– –
LMT icon
36
Lockheed Martin
LMT
$132B
$855K 0.3%
2,090
– –
WBD icon
37
Warner Bros
WBD
$63.9B
$744K 0.26%
68,504
-1,161
-2% -$14.5K
CL icon
38
Colgate-Palmolive
CL
$73.3B
$631K 0.22%
8,875
– –
EMR icon
39
Emerson Electric
EMR
$83.3B
$536K 0.19%
5,547
– –
K
40
DELISTED
Kellanova
K
$530K 0.19%
+9,477
New +$564K
VNQ icon
41
Vanguard Real Estate ETF
VNQ
$39.4B
$374K 0.13%
4,942
– –
TJX icon
42
TJX Companies
TJX
$176B
$365K 0.13%
4,107
+15
+0.4% +$1.32K
SO icon
43
Southern Company
SO
$109B
$356K 0.12%
5,508
– –
ACN icon
44
Accenture
ACN
$99.9B
$333K 0.12%
1,085
+4
+0.4% +$1.26K
CVS icon
45
CVS Health
CVS
$134B
$319K 0.11%
4,571
– –
VTRS icon
46
Viatris
VTRS
$20.7B
$267K 0.09%
27,118
-39
-0.1% -$406
BLK icon
47
Blackrock
BLK
$170B
$239K 0.08%
369
– –
JPM icon
48
JPMorgan Chase
JPM
$933B
$205K 0.07%
1,413
– –
AMGN icon
49
Amgen
AMGN
$209B
– –
-30,866
Closed -$6.85M
1
2

Similar funds

PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return
AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return

Keystone Financial Planning's Q3 2023 Portfolio in Review

As of Q3 2023, Keystone Financial Planning held 49 positions worth $286M, down 4.2% from $299M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Keystone Financial Planning's Q3 2023 filing shows 2 new, 12 increased, 18 reduced and 1 closed positions. Its largest new stake was Bristol-Myers Squibb: 115,429 shares worth $6.7M. The largest sale was Amgen, an estimated $6.85M.

By sector, the portfolio is most concentrated in Consumer Staples at 8.8% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

  • Keystone Financial Planning's largest Q3 2023 buy was Bristol-Myers Squibb: 115,429 shares worth $6.7M.
  • Keystone Financial Planning added most to Pfizer in Q3 2023, an estimated $482K increase.
  • Keystone Financial Planning's biggest Q3 2023 reduction was IBM, cutting an estimated $312K.
  • Keystone Financial Planning fully exited Amgen in Q3 2023, selling an estimated $6.85M.
  • Keystone Financial Planning's ten largest holdings make up 65% of its $286M portfolio in Q3 2023.
  • Keystone Financial Planning opened 2 new positions and closed 1 in Q3 2023.
  • Keystone Financial Planning's portfolio value fell 4.2% quarter-over-quarter to $286M.

Based on Keystone Financial Planning's 13F filing for Q3 2023, filed 10 Oct 2023.